PSTC100 Study in Healthy Adult Subjects
This study is a single-center, randomized, double-blind, placebo-controlled, dose-escalation phase I clinical trial designed to evaluate the safety, tolerability, pharmacokinetic, and pharmacodynamic (PD) characteristics of PSTC100 in healthy adult subjects.
1.Fully understand the purpose and process of this study, voluntarily participat... [+6]
1.Pregnant women (or those with a positive pregnancy test), or breastfeeding wom... [+17]